文献速递疼痛医学

心理健康筛查工具评估神经调控植入前心理访谈必要性

Evaluation of a mental health screening tool to determine the need for psychological interview for patients offered neuromodulation implant therapies for pain.
PubMed 文献 · Reg Anesth Pain Med · 2026-09-10

两组试验至植入率(72% vs 70%)及植入后1年应答率(53% vs 60%)无显著差异,筛查工具可有效甄别可跳过常规心理评估的患者。

要点

  • 筛查阳性者接受心理评估,阴性者直接进入试验,两组1年结局相当。
  • 基线疼痛强度较高和使用三环类抗抑郁药与植入失败相关。
  • 疼痛病程超过10年与植入成功相关。

核心结论

  • 该筛查工具能有效识别可跳过常规心理评估而不影响1年脊髓电刺激结局的患者。

主要发现

  • 两组试验至植入率相似(72% vs 70%,p=0.811)。
  • 植入后1年应答率(疼痛较基线减少≥30%)两组相当(53% vs 60%,p=0.927)。
  • 多因素logistic回归显示基线疼痛强度较高(aOR 0.70,95%CI 0.53-0.92,p=0.011)和使用三环类抗抑郁药(aOR 0.15,95%CI 0.04-0.56,p=0.005)与植入失败相关。
  • 疼痛病程超过10年与植入成功相关(aOR 3.09,95%CI 1.06-9.02,p=0.039)。

关键数值与推荐

  • 筛查工具采用经验证问卷的阈值评估焦虑、抑郁、灾难化思维和阿片类药物滥用风险,并结合清单记录显著焦虑抑郁、自伤、物质滥用或心理健康相关住院。
  • 筛查阳性者接受正式心理评估,阴性者直接进入试验(快速通道)。
  • 植入成功定义为疼痛较基线减少≥30%。

临床怎么用

  • 采用该筛查工具可优化患者流程,缩短等待时间,并将心理资源集中于需要正式评估的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Psychological comorbidities can negatively impact outcomes of spinal cord stimulation (SCS) for chronic pain. While psychological assessment is commonly required before SCS implantation, evidence supporting its impact on outcomes is limited, and such assessments may be unnecessary for many patients and contribute to delays in care. Our center implemented a screening tool incorporating validated questionnaires and a mental health checklist to triage the need for formal psychological evaluation. This prospective, observational cohort study compared outcomes of SCS trials and implants between patients who bypassed (fast track: FT) versus those who underwent a formal assessment by a psychologist (AP). METHODS: Data were collected from patients undergoing SCS trials between July 2017 and December 2021. The screening tool used thresholds on validated questionnaires assessing anxiety, depression, catastrophizing, and opioid misuse risk, along with a checklist capturing significant anxiety or depression, self-harm, substance abuse, or mental-health-related hospitalization. Patients screening positive underwent an AP; others proceeded directly to trial (FT). 1 year post implantation outcomes were collected, with successful implantation defined as ≥30% pain reduction from baseline. RESULTS: Of 171 patients (114 AP, 57 FT), trial-to-implant rates were similar (72% AP vs 70% FT, p=0.811). The proportion of responders at 1 year post implant was also comparable (53% AP vs 60% FT, p=0.927). Multivariate logistic regression identified that higher baseline pain intensity (adjusted OR (aOR) 0.70, 95% CI 0.53 to 0.92, p=0.011) and use of tricyclic antidepressants (aOR 0.15, 95% CI 0.04 to 0.56, p=0.005) were associated with implant failure, whereas pain duration >10 years was associated with implant success (aOR 3.09, 95% CI 1.06 to 9.02, p=0.039). CONCLUSIONS: This screening tool effectively identifies patients who can bypass routine psychological assessment without compromising 1 year SCS outcomes. Implementation can streamline patient flow, reduce wait times, and reserve psychological resources for those who need formal evaluation.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Xiao MZX, Curtis K, Muere A, et al. Evaluation of a mental health screening tool to determine the need for psychological interview for patients offered neuromodulation implant therapies for pain. Reg Anesth Pain Med. 2026. PMID: 41781150. doi:10.1136/rapm-2025-107507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。